Hormone replacement therapy is associated with improved survival in women with advanced heart failure (Q46077959)

19 December 2017

title

Hormone replacement therapy is associated with improved survival in women with advanced heart failure (English)

1 reference

19 December 2017

Hormone Replacement Therapy

main subject

1 reference

12

1 reference

19 December 2017

Clyde Yancy

8

object named as

Clyde Yancy

1 reference

19 December 2017

7

Mary Ann Peberdy

1 reference

19 December 2017

JoAnn Lindenfeld

1

1 reference

19 December 2017

Jalal K Ghali

2

1 reference

19 December 2017

Heidi J Krause-Steinrauf

3

1 reference

19 December 2017

Steven Khan

4

1 reference

19 December 2017

Kirkwood Adams

5

1 reference

19 December 2017

Steven Goldman

6

1 reference

19 December 2017

Surai Thaneemit-Chen

9

1 reference

19 December 2017

Rhonda L Larsen

10

1 reference

19 December 2017

James Young

11

1 reference

19 December 2017

Yves D Rosenberg

13

1 reference

19 December 2017

BEST Investigators

14

1 reference

19 December 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

19 December 2017

Journal of the American College of Cardiology

published in

1 reference

19 December 2017

volume

42

1 reference

19 December 2017

issue

7

1 reference

19 December 2017

page(s)

1238-1245

1 reference

19 December 2017

The epidemiology of heart failure: the Framingham Study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Prevalence and mortality rate of congestive heart failure in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Estrogen is associated with improved survival in aging women with congestive heart failure: analysis of the vesnarinone studies

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Design of the Beta-Blocker Evaluation Survival Trial (BEST). The BEST Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Acute vascular effects of estrogen in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Prognostic value of plasma endothelin-1 in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Adrenergic nervous system in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Hormone replacement therapy in postmenopausal women with essential hypertension increases circulating plasma levels of bradykinin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Effect of long-term hormone replacement therapy on angiotensin-converting enzyme activity and bradykinin in postmenopausal women with essential hypertension and normotensive postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Impact of age on echocardiographic left ventricular mass in a healthy population (the Framingham Study).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Sex differences in cardiac adaptation to essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Effect of hormone replacement therapy on left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Sex differences in cardiac adaptation to isolated systolic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Sex-associated differences in left ventricular function in aortic stenosis of the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Gender differences in left ventricle geometry and function in patients undergoing balloon dilatation of the aortic valve for isolated aortic stenosis. NHLBI Balloon Valvuloplasty Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Gender differences in left ventricular function at rest and with exercise in asymptomatic aortic stenosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Impact of chamber geometry and gender on left ventricular systolic function in patients > 60 years of age with aortic stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Alterations of cardiac performance in rats with established spontaneous hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Gender differences in molecular remodeling in pressure overload hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Cardiac myocytes and fibroblasts contain functional estrogen receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

17beta-estradiol attenuates the development of pressure-overload hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Differential Activation of Signal Transduction Pathways in Human Hearts With Hypertrophy Versus Advanced Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Gender differences and aging: effects on the human heart

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Myocardial Akt activation and gender: increased nuclear activity in females versus males

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Postmenopausal estrogen and prevention bias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Coronary heart disease and estrogen replacement therapy. Can compliance bias explain the results of observational studies?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

The relationship of treatment adherence to the risk of death after myocardial infarction in women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Fixing the failing heart

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

10.1016/S0735-1097(03)00938-0

Identifiers

DOI

1 reference

19 December 2017

PubMed ID

14522488

1 reference

19 December 2017